International Molecular Biology of HBV Conference Report

First of all, I would like to thank the AFCC for giving me the opportunity to attend the 2015 International Meeting on Molecular Biology of HBV held in Frankfurt, Germany from 4 October to 8 October .Those conferences were very interesting and gave the opportunity to learn many issues in regards to laboratory medicine at large. As a member of the African Federation of Clinical Chemistry and Laboratory Medicine, it was a very enriching experience for me to attend the conference.

I will describe briefly below the different aspects discussed in the conference.

1. Chronic HBV as a major risk factor for HCC
2. HBx activates Ftx, which is an IncRNA that contains a potentially oncogenic miRNA cluster
3. How binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism
4. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing …

The conferences were well attended. Many healthcare experts in different divisions of pathology from different corners of the world were at the conference.
The conference kicked off with a detailed discussion of the aspects of the biology of hepatitis B and hepatitis D, including biochemistry, molecular biology, traditional virology, immunology, pathogenesis, and carcinogenesis, as well as the latest developments in antiviral therapies against these two viruses in form of oral and poster presentations.
I managed to get some advices on how to further my research especially the molecular aspect of HBV among the HIV-HBV coinfected individuals.
Again, thank you very much for your sponsorship
Alfred Makura

Chemical Pathology Research Assistant/Intern
Department of Chemical Pathology
Division of Pathology
College of Health Sciences
University of Zimbabwe